• Same price every dose
  • Licensed US providers
  • Care in all 50 states + Puerto Rico
  • Only pay if prescribed
  • No hidden fees
  • 503A pharmacies
  • HSA and FSA eligible
  • Delivered to your door
Article

Semaglutide for Women: How It Works and How to Start

How semaglutide works for weight loss in women, what to expect, safety, and cost, plus how to start with Elara from $247/month, all-in.

By Elara Care Team

An Elara compounded GLP-1/GIP vial with an insulin syringe

Semaglutide is a once-weekly injectable medication that helps with weight loss by acting like a natural gut hormone (GLP-1) that lowers appetite, increases fullness, slows how fast your stomach empties, and steadies blood sugar. In the STEP 1 trial, adults taking semaglutide 2.4 mg alongside lifestyle changes lost about 15% of their body weight over 68 weeks. It is prescription-only, and a licensed provider should decide whether it fits your health, your hormones, and your goals.

This is the women's guide to semaglutide: what it is, how much weight women tend to lose, the difference between Wegovy, Ozempic, and compounded semaglutide, what to know about PCOS, menopause, periods, and pregnancy, the real safety picture, and what it costs at Elara.

Key takeaways

  • Semaglutide is a GLP-1 receptor agonist. It curbs appetite, increases fullness, slows stomach emptying, and helps regulate blood sugar.
  • The evidence is strong. In the STEP 1 trial, adults lost about 14.9% of body weight over 68 weeks with semaglutide 2.4 mg plus lifestyle support. Individual results vary and depend on the full program, nutrition, activity, and dose.
  • Names matter. Wegovy is the FDA-approved semaglutide for chronic weight management. Ozempic is FDA-approved for type 2 diabetes; using it for weight loss is off-label.
  • Safety is real and manageable. Semaglutide carries a boxed warning for thyroid C-cell tumors and is not for use in pregnancy. A clinician reviews your history first.
  • Elara offers compounded semaglutide from $247/month, all-in (and branded options). Compounded medications are not FDA-approved.

What is semaglutide, and how does it work for weight loss?

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally releases after you eat. Semaglutide mimics that hormone, but at a much steadier, longer-lasting level.

According to Cleveland Clinic, semaglutide works on several fronts at once:

  • It quiets appetite and food noise. It acts in the appetite centers of your brain (the hypothalamus and hindbrain), so you feel hungry less often and think about food less.
  • It increases fullness. You feel satisfied sooner and stay satisfied longer, so meals get smaller without white-knuckle willpower.
  • It slows gastric emptying. Food leaves your stomach more slowly, which stretches out that "full" feeling, and is also why some early side effects are digestive.
  • It steadies blood sugar. It prompts the pancreas to release insulin when blood sugar is high, which helps with cravings and energy dips.

Put together, most people simply eat less without feeling deprived. That is the mechanism, not a metabolism "boost," not fat-burning, and not a substitute for eating and moving in a way that supports you. Semaglutide makes those habits far easier to sustain.

How much weight can women lose on semaglutide?

The clearest answer comes from the STEP 1 trial, published in the New England Journal of Medicine in 2021. Adults with overweight or obesity who took semaglutide 2.4 mg once weekly, along with lifestyle counseling, lost on average about 14.9% of their body weight over 68 weeks, far more than the roughly 2.4% seen with lifestyle changes alone. For someone starting at 200 pounds, roughly 15% is about 30 pounds.

A few honest caveats belong right next to that number:

  • These results come from trials of FDA-approved branded semaglutide (the kind sold as Wegovy). Compounded semaglutide has not been studied in the same large trials.
  • Individual results vary. Trial averages describe a group. Your result depends on your starting point, your dose, how your body responds, and the daily inputs, protein, fiber, movement, sleep, and consistency.
  • Weight loss is not linear. Plateaus are normal and expected. If the scale stalls, that usually means it is time to troubleshoot, not to quit, our guide to why you might not be losing weight on semaglutide walks through the common reasons.

Protecting muscle while you lose fat matters, especially for women. Rapid weight loss of any kind can cost lean muscle along with fat, which is why protein and resistance training are part of the plan, see how women can keep muscle on a GLP-1.

Wegovy, Ozempic, and compounded semaglutide: what's the difference?

All three contain the molecule semaglutide, but they are not interchangeable, and the labels matter for both safety and honesty.

ProductWhat it isFDA status
WegovySemaglutide 2.4 mg, once weeklyFDA-approved for chronic weight management in adults (and adolescents 12+) with obesity, or overweight plus a weight-related condition
OzempicSemaglutide, once weeklyFDA-approved for type 2 diabetes. Using it for weight loss is off-label
Compounded semaglutideSemaglutide prepared for an individual patient by a state-licensed compounding pharmacyNot FDA-approved and not reviewed by the FDA for safety, effectiveness, or quality

Compounded semaglutide is prepared by a state-licensed compounding pharmacy and prescribed by a licensed clinician when it is appropriate for you. It is not a "generic" version of Wegovy or Ozempic, and it has not been through the FDA approval process that the branded products have. Some women choose a compounded option for cost and access reasons; that is a decision to make with a clinician, with the full picture in front of you.

About compounded medications: Compounded semaglutide and tirzepatide are prepared by a
state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate for you.
**Compounded medications are not FDA-approved and are not reviewed by the FDA for safety,
effectiveness, or quality.** They are not "generic" versions of Ozempic®, Wegovy®, Mounjaro®, or
Zepbound®. Talk to a licensed clinician about whether a compounded or FDA-approved option is right for you.

What should women specifically know about semaglutide?

Most semaglutide information is written for a general audience. But female physiology changes the conversation in ways that are easy to miss, and that is exactly where women get under-served.

PCOS and insulin resistance

Polycystic ovary syndrome (PCOS) is driven largely by insulin resistance and weight, so a medication that improves both can make a real difference. In a large real-world analysis from Epic Research, women with PCOS on a GLP-1 lost a median of 11.5% of their body weight at one year, versus 1.9% on metformin, and 55.7% of GLP-1 users reached at least 10% weight loss, compared with 13.7% on metformin. No GLP-1 is FDA-approved specifically for PCOS, so this use is off-label and should be guided by a clinician. If PCOS is your reason for being here, start with our guide to GLP-1s and your period.

Your menstrual cycle

Many women notice their cycle shifts on semaglutide, often becoming more regular. This is usually indirect: losing fat and improving insulin sensitivity changes hormone balance, which can restart or regularize periods (a meaningful effect for PCOS). Some report lighter or more irregular cycles early on. We cover this in depth in does semaglutide affect your period.

Birth control

Here is a women-specific point worth underlining: semaglutide is not known to reduce the effectiveness of birth control pills. That warning applies to tirzepatide, the dual-action molecule, not semaglutide, which is one of the real differences between the two. If you are weighing the two options, see our tirzepatide guide.

Pregnancy and trying to conceive

Semaglutide is not recommended during pregnancy or breastfeeding, and it is not a fertility drug. Because weight loss and better insulin sensitivity can restore ovulation, some women conceive unexpectedly. Current guidance is to stop semaglutide about two months before trying to conceive, see when to stop semaglutide before pregnancy. Always plan this with your provider.

Is semaglutide safe? Side effects and warnings

For most people, semaglutide is well-tolerated, but it is a real medication with real cautions. The most common side effects are digestive, nausea, diarrhea, constipation, vomiting, and reflux, and they tend to be worst when you first start or increase your dose, then ease over time. Starting low and increasing slowly (titration) is designed to limit them, and what you eat helps too; see what to eat on semaglutide and the standard semaglutide dosage chart.

The serious risks you should know, per the FDA prescribing information:

  • Boxed warning, thyroid C-cell tumors. In rodents, semaglutide caused thyroid C-cell tumors at clinically relevant doses; whether it does so in humans is unknown. Semaglutide is contraindicated if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Pancreatitis. Stop and seek care for severe, persistent abdominal pain (which may radiate to the back).
  • Gallbladder disease. Rapid weight loss can raise gallstone risk.
  • Low blood sugar (hypoglycemia). More likely if you also take insulin or a sulfonylurea.
  • Kidney injury, usually tied to dehydration from vomiting or diarrhea, and other cautions including eye (retinopathy) and gallbladder effects.

This list is not exhaustive. Semaglutide is prescription-only for good reason: talk to a licensed provider about your history before starting, and read the FDA prescribing information for the specific product you are prescribed.

A closeup of a woman's face

How much does semaglutide cost?

Cost is often the deciding factor, and the range is wide. Brand-name Wegovy lists at about $1,349 per month (NovoCare), before insurance or savings programs. Elara takes a different, cash-pay approach with no insurance hurdles and no separate membership fee.

Elara compounded semaglutide (all-inclusive):

PlanTotal price≈ per month
Monthly$247$247/mo
Quarterly (3 mo)$590$197/mo
6-month$1,190$198/mo
12-month$2,380$198/mo

Every plan includes the provider visit, the medication, shipping, ongoing access to Elara's medical team, the private community, and the Elara app, not just the vial. Elara also offers branded Wegovy and Ozempic (Ozempic is FDA-approved for type 2 diabetes; its use for weight loss is off-label); branded pricing is listed on each medication page and finalized at checkout.

A note on comparing prices honestly: brand-name Wegovy lists around $1,349/month, and Elara's compounded semaglutide program starts at $247/month, all-in, but that is a comparison of price and access, not of sameness. Compounded medications are not FDA-approved. For the full breakdown, see our semaglutide cost guide.

No, compounded semaglutide is not FDA-approved, and it is not reviewed by the FDA for safety, effectiveness, or quality. It is legally prepared by state-licensed compounding pharmacies for individual patients when a licensed clinician determines there is a documented clinical need.

The 2026 landscape is worth understanding plainly:

  • The FDA declared the semaglutide shortage resolved on February 21, 2025 (tirzepatide, December 19, 2024). Compounding here is not based on a shortage.
  • Broad, shortage-based compounding wound down in 2025. Narrow, patient-specific compounding under section 503A survives when there is a documented clinical need.
  • On April 30, 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B "bulks" list; the public comment period was extended to July 30, 2026. This is a proposal, not a final rule, and the situation can change.
  • Regulators are watching this space closely. The FTC finalized a deceptive-marketing order against telehealth GLP-1 seller NextMed in December 2025 over hidden costs and fake testimonials, a reminder to choose a provider that is transparent and clinician-led.

Because this is a moving area, it is worth confirming you are working with a legitimate program, see is it safe to get semaglutide online. This is general information, not legal advice.

How Elara helps

Elara is a women-first telehealth program built around GLP-1 weight loss and the supporting care that goes with it. Here is how it works:

  1. You start with a quick eligibility check. A licensed provider reviews every patient, your history, your goals, PCOS or thyroid concerns, birth control, and pregnancy plans. Depending on your state and whether you are a first-time or returning patient, that review may be synchronous or asynchronous.
  2. If semaglutide is appropriate for you, it's prescribed, branded or compounded, and shipped to your door from a licensed pharmacy.
  3. You get everything included: the visit, the medication, shipping, ongoing access to Elara's medical team, the private community, the app, recipes, and workouts. 7-day-a-week human support. No insurance runaround, no surprise fees, available in all 50 states and Puerto Rico.

Considering semaglutide? Elara's compounded semaglutide program starts at $247/month (about $198/month on the 12-month plan), all-inclusive: your provider visit, medication, shipping, ongoing support, and the Elara app. A licensed provider reviews every patient.

Start your free eligibility check → · Explore Elara's weight-loss program →

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.

Frequently asked questions

How does semaglutide work for weight loss? Semaglutide is a GLP-1 receptor agonist. It mimics a natural gut hormone that reduces appetite, increases fullness, slows how quickly your stomach empties, and helps steady blood sugar. The result is that most people eat less without feeling deprived, which supports gradual, sustained weight loss alongside nutrition and activity.

Is semaglutide safe for women? For most women it is well-tolerated, but it is a prescription medication with real cautions. It carries a boxed warning for thyroid C-cell tumors and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. It is not for use in pregnancy. A licensed provider should review your history first.

How much weight can you lose on semaglutide? In the STEP 1 trial, adults lost about 14.9% of their body weight over 68 weeks on semaglutide 2.4 mg plus lifestyle changes. Individual results vary and depend on your dose, your body, and daily inputs like protein, movement, and sleep. Trial averages describe a group, not a promise.

How much does semaglutide cost at Elara? Elara's compounded semaglutide starts at $247/month and drops to about $198/month on the 12-month plan, all-inclusive of the provider visit, medication, shipping, support, and the app. Branded Wegovy lists around $1,349/month elsewhere. Compounded medications are not FDA-approved.

Is compounded semaglutide FDA-approved? No. Compounded semaglutide is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality. It is prepared by a state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate. It is not a generic version of Wegovy or Ozempic.

How do I start with Elara? Begin with a short eligibility check. A licensed provider reviews your health history and goals, and if semaglutide is appropriate, it is prescribed and shipped to your door. You get ongoing access to Elara's medical team, the app, and 7-day human support, in all 50 states and Puerto Rico.

The bottom line

Semaglutide is one of the most effective weight-loss medications available, and for women it can do more than move the scale, it can improve insulin sensitivity, cycles, and PCOS symptoms. It is also a real medication with real warnings, so the right first step is a conversation with a licensed provider. If you want a women-first program with transparent, all-inclusive pricing, Elara starts at $247/month for compounded semaglutide, and a clinician reviews every patient.

References

  1. Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (STEP 1). New England Journal of Medicine, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  2. U.S. Food and Drug Administration. "WEGOVY (semaglutide), Prescribing Information," including boxed warning and indication. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  3. Cleveland Clinic. "GLP-1 Agonists: How They Work," covering appetite, satiety, gastric emptying, and insulin release. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
  4. Epic Research. "GLP-1s Lead to Greater Weight Loss and A1C Improvement Than Metformin in Patients with PCOS," 2025. https://www.epicresearch.org/articles/glp-1s-lead-to-greater-weight-loss-and-a1c-improvement-than-metformin-in-patients-with-pcos/
  5. NovoCare. "Wegovy List Price." https://www.novocare.com/patient/medicines/wegovy.html
  6. U.S. Food and Drug Administration. "FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize." https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  7. U.S. Food and Drug Administration. "FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List," 2026. https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list
  8. Federal Trade Commission. "FTC Approves Final Order against Telehealth Provider NextMed Over Charges It Used Deceptive Advertising Claims to Sell GLP-1 Weight-Loss Programs," December 2025. https://www.ftc.gov/news-events/news/press-releases/2025/12/ftc-approves-final-order-against-telehealth-provider-nextmed-over-charges-it-used-deceptive
This article is for general education and is not medical advice. It doesn't replace a conversation
with a licensed clinician about your health, medications, or treatment. Reading it doesn't create a
doctor-patient relationship. If you have a medical emergency, call 911. See our full
Medical Disclaimer.
About compounded medications: Compounded semaglutide and tirzepatide are prepared by a
state-licensed compounding pharmacy and prescribed by a licensed clinician when appropriate for you.
**Compounded medications are not FDA-approved and are not reviewed by the FDA for safety,
effectiveness, or quality.** They are not "generic" versions of Ozempic®, Wegovy®, Mounjaro®, or
Zepbound®. Talk to a licensed clinician about whether a compounded or FDA-approved option is right for you.

Keep reading